Finland, Russia have no serious problems in their relations — top diplomatWorld February 27, 21:49
Brazil's joyful carnivalSociety & Culture February 27, 21:30
Syrian opposition has no dialog partner seeking peace — chief negotiatorWorld February 27, 20:37
About 40 Arctic projects may be in Russia's Yamal backbone zone — governorBusiness & Economy February 27, 19:28
Russian Defense Ministry forms special purpose division near MoscowMilitary & Defense February 27, 19:13
Russian frigate in Mediterranean to deliver no strikes on terrorists in Syria — sourceMilitary & Defense February 27, 18:54
First stage of Arkhangelsk deepwater port to go operational by 2025Business & Economy February 27, 18:45
Cairo group says military option in Syria 'ruled out' after recapture of AleppoWorld February 27, 18:31
Communication breakdown between Russia and EU deters fight against real threats — MPRussian Politics & Diplomacy February 27, 17:40
MOSCOW, October 29. /TASS/. The Federal Antimonopoly Service (FAS) wants to introduce a simplified procedure for admission of medicines, previously registered in the US and Europe to Russia, the head of FAS Igor Artemyev said on Thursday speaking at a cabinet session.
"It is necessary to check the history [of these medicines]. This system should not be automatic, we have to check, but if it was registered in the United States or Europe, there must be a simplified procedure for the introduction of these medicines in the Russian Federation," he said.
Artemyev also said that in the next five years a new section for the development of competition in the healthcare sector should be added to the competition development program.
"It is necessary to add an aspect about the sale of medicines via retail chains there. I would say that the issue of substitution should be solved not by 2018 but by 2017. This will have a significant effect on prices and improve competition in healthcare sector," he said.